[
  {
    "ts": "2025-09-10T10:30:00+00:00",
    "headline": "Exact Sciences Launches Cancerguard™, First-of-Its-Kind Multi-Cancer Early Detection Blood Test",
    "summary": "MADISON, Wis., September 10, 2025--Exact Sciences Corp. (Nasdaq: EXAS), a leader in cancer diagnostics, today announced the launch of the Cancerguard™ test, a new multi-cancer early detection (MCED) blood test that is now available as a laboratory-developed test (LDT) in the United States. Cancerguard is the first MCED test commercially available that analyzes multiple biomarker classes to help detect a wide range of cancers, including those that often go undiagnosed until later stages when trea",
    "url": "https://finance.yahoo.com/news/exact-sciences-launches-cancerguard-first-103000596.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "3099da8c-9357-3a57-8e1d-871d765885fa",
      "content": {
        "id": "3099da8c-9357-3a57-8e1d-871d765885fa",
        "contentType": "STORY",
        "title": "Exact Sciences Launches Cancerguard™, First-of-Its-Kind Multi-Cancer Early Detection Blood Test",
        "description": "",
        "summary": "MADISON, Wis., September 10, 2025--Exact Sciences Corp. (Nasdaq: EXAS), a leader in cancer diagnostics, today announced the launch of the Cancerguard™ test, a new multi-cancer early detection (MCED) blood test that is now available as a laboratory-developed test (LDT) in the United States. Cancerguard is the first MCED test commercially available that analyzes multiple biomarker classes to help detect a wide range of cancers, including those that often go undiagnosed until later stages when trea",
        "pubDate": "2025-09-10T10:30:00Z",
        "displayTime": "2025-09-10T10:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/5c9741afba03f97e20fbae501b1140a4",
          "originalWidth": 480,
          "originalHeight": 384,
          "caption": "The Cancerguard test kit",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/mF8qPPfmXfG.Nl_m17pSZA--~B/aD0zODQ7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/5c9741afba03f97e20fbae501b1140a4.cf.webp",
              "width": 480,
              "height": 384,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OpY4iwJvYgw3_bwKdjZyBA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/5c9741afba03f97e20fbae501b1140a4.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/exact-sciences-launches-cancerguard-first-103000596.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/exact-sciences-launches-cancerguard-first-103000596.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "EXAS"
            },
            {
              "symbol": "DGX"
            },
            {
              "symbol": "META"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]